Shared clinical decision making on vaccines: Nothing has really changed for pharmacists

Area of Science:

• Public Health
• Immunization Practices
• Clinical Pharmacy

Background:

• The Centers for Disease Control and Prevention (CDC) introduced Shared Clinical Decision-Making (SCDM) for vaccine recommendations.
• This approach emphasizes collaborative conversations between healthcare providers and patients regarding immunization.
• Existing understanding and implementation of SCDM among healthcare professionals, particularly pharmacists, require clarification.

Purpose of the Study:

• To clarify the intent and definition of Shared Clinical Decision-Making (SCDM) in vaccine recommendations.
• To address and dispel common misconceptions or myths surrounding SCDM.
• To reinforce the role of pharmacists in patient immunization and decision-making.

Main Methods:

• This is a commentary, not an empirical study.
• Analysis of the CDC's recommendation on Shared Clinical Decision-Making.
• Discussion of the implications for pharmacy practice and patient counseling.

Main Results:

• Shared Clinical Decision-Making (SCDM) aims to enhance patient-provider dialogue about vaccines.
• Misinterpretations of SCDM may lead to confusion regarding provider responsibilities.
• The core recommendation is for continued, active engagement in patient immunization.

Conclusions:

• Pharmacists should understand Shared Clinical Decision-Making (SCDM) as a tool for enhanced patient communication, not a barrier to immunization.
• Clarification of SCDM terminology is crucial to prevent confusion and maintain high vaccination rates.
• Healthcare providers must continue to proactively recommend and administer vaccines based on established guidelines and patient needs.